Last reviewed · How we verify
NCT04911387
iCare® Home vs Goldmann Applanation Tonometry
trial testing Intraocular pressure measurments in Glaucoma in 61 participants. Completed in 31 October 2020.
31 October 2020
Quick facts
| Lead sponsor | St. Erik Eye Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 61 |
| Start date | 1 April 2020 |
| Primary completion | 31 October 2020 |
| Estimated completion | 31 October 2020 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Intraocular pressure measurments
Conditions studied
- Glaucoma — all drugs for Glaucoma →
- Open Angle Glaucoma — all drugs for Open Angle Glaucoma →
- Ocular Hypertension — all drugs for Ocular Hypertension →
- Pseudo Exfoliation Syndrome — all drugs for Pseudo Exfoliation Syndrome →
Sponsor
St. Erik Eye Hospital
Who can join
18 and older, any sex, with Glaucoma or Open Angle Glaucoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Self-tonometry with iCare Home is regularly performed at Sankt Erik's Eye Hospital since a few years back. The purpose of this study was to show that the eye pressure measurements made with iCare® Home by patients / relatives do not vary more than those made with the standard method, Goldman applanation tonometry (GAT), by different healthcare professionals. This will hopefully confirm the usefulness of self-tonometry.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04911387
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Glaucoma
Currently open trials in the same condition.
- NCT07455786 — Modified Trabeculectomy After Failure of Combined Phaco With GATT · NA · recruiting
- NCT07298356 — Automated Applanation Tonometry - Updated · NA · recruiting
- NCT07217678 — Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use · Phase 4 · recruiting
- NCT07145073 — Repetitive Transcranial Alternating Current Stimulation (rtACS) for the Treatment of Optic Neuropathies · NA · recruiting
- NCT07209410 — Evaluating Injection With the Use of Brimonidine Tartrate Ophthalmic 0.025% on Patients Using Netarsudil 0.02%/Latanopro · Phase 4 · recruiting
Other St. Erik Eye Hospital trials
Trials by the same sponsor.
- NCT06717139 — Recurrence and Predictive OCT Biomarkers in Quiescent Neovascular AMD · active not recruiting
- NCT04888156 — Impact of Self-tonometry on Glaucoma Treatment Decision. · completed
- NCT04150263 — Modification of Scleral Suture Fixation of Dislocated IOL · NA · completed
- NCT03709745 — Eylea and Lucentis for Macular Edema in Branch Retinal Vein Occlusion · Phase 4 · completed
- NCT03445806 — IOP Monitoring After Trabeculectomy Using iCare Home · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04911387 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by St. Erik Eye Hospital
- Last refreshed: 3 June 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04911387.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing